What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News VHIR participates in the EU Project SPM4.0 Researchers from all over Europe gathered to kick off the SPM4.0 project, an innovative Marie Curie Skłodowska (MSCA-DN) doctoral network that promotes the development of autonomous Scanning Probe Microscopy with AI. News Vall d'Hebron has participated in an international clinical trial for a new treatment for resistant hypertension Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study. News Vall d'Hebron has helped to launch the new HUB Alzheimer Barcelona, which seeks to transform how the disease is researched and treated This project is promoted by the Pasqual Maragall Foundation with the support of Barcelona City Council. It involves some of the city's main public hospitals and institutions specialising in research into Alzheimer's disease. News Tesai Care launches a pioneering clinical trial with heecap to prevent respiratory muscle atrophy in mechanically ventilated patients The Parc Taulí and Vall d’Hebron spin-off has raised €2.77 million in private and public funds, enabling it to complete the necessary clinical trials to obtain CE marking and bring this device to market. News Vall d'Hebron develops a predictive model to calculate cardiovascular risk in women Vall d'Hebron researchers have created a score based on multiple clinical variables and cardiac images, specific to women, to identify patients at risk of severe complications such as a heart attack or sudden death News Vall d'Hebron has participated in a clinical study that has demonstrated the efficacy of gene therapy in patients with Fanconi anaemia for the first time The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up. Activities Jornades d’Actualització en Virus Respiratoris (2024): la Vigilància Integral de la Grip des de la Perspectiva OneHealth ONLINE News Vall d'Hebron is participating in the INDICATE project to improve the access to and exchange of data between intensive care units throughout Europe INDICATE will lay the foundations for the training and operation of an AI model implemented in intensive care units to support personalised medicine applications, data comparison between ICUs and preparedness for possible disasters. News Vall d'Hebron hosts a congress on translational research in head and neck cancer The sessions were aimed at establishing new collaborations to advance the prevention and treatment of this type of tumour. Activities Defensa de Tesi 'Nivells de cortisol (sèric matutí, salivar nocturn, lliure urinari 24h i test de supressió amb 1mg de Dexametasona) en pacients amb obesitat severa i en relació amb la cirurgia bariàtrica' Doctoranda: Anna Casteras Román, Diabetis i metabolisme (VHIR) Directores: Dra. Andreea Ciudin Mihai i Dra. Betina Biagetti Biagetti Tutora: Dra. Andreea Ciudin Mihai News The President of the Generalitat inaugurates the new Vall d’Hebron Research Institute building A 17,000 m2 space dedicated to research, innovation and teaching, which is open to the public. Activities Congress: Translational research in HNSCC: New challenges for future therapies https://aula.vallhebron.com/index.php?go=info_cursos&curso=696 Head and neck cancer is an understudied disease with a high relapse and mortality rate. Therapeutic modalities have not si Activities Jornada 'L'accés a assaigs clínics per a persones amb VIH' Modera: Dr. Adrià Curran, investigador principal del grup de Malalties Infeccioses del VHIR i facultatiu del Servei de Malalties Infeccioses de l'Hospital Universitari Vall d'Hebron Participen: Hernan Perea, StopSida Juanse Hernánd Activities Defensa de Tesi 'ARTERIAL: an AI framework for the automated characterization of vascular tortuosity' Doctorand: Pere Canals Canals. Grup de Recerca en ictus (VHIR) Directors: Dr. Marc Ribó i Dr. Simone Balocco Tutor: Dr. José Álvarez Sabin News An international study has shown that the drug semaglutide, administered to treat obesity and diabetes, protects the kidney in obese people with kidney disease The new findings were presented at the American Society of Nephrology's Kidney Week 2024 meeting in San Diego and simultaneously published in the prestigious journal Nature Medicine. Activities III Curso Impacto de las nuevas Tecnologías en el Control de la Diabetes Aula Vall d'Hebron Secretaría Técnica actividades formativas externas Mail: inscripcions@aulavallhebron.cat tel: 693.785.436 Activities Xerrades 30 anys VHIR 'Recerca bàsica més clínica en benefici del pacient: ictus' A partir del mes de setembre i en el marc dels actes de celebració del 30 aniversari del Vall d’Hebron Institut de Recerca, hem organitzat un cicle de sis xerrades entre els nostres investigadors i investigadores, pacients, familiars i represent News Launch of POC4TRIAGE: Revolutionizing Urgent Care with Innovative Point-of-Care Technologies A new consortium of leading organizations embarks on a groundbreaking project to enhance patient triage and healthcare delivery. News A study by Vall d'Hebron and UB suggests wild boars could be a potential source of hepatitis E transmission to humans in the Barcelona metropolitan area Over time, wild boars have approached the city of Barcelona and surrounding areas. As carriers of the hepatitis E virus, they are linked to a study identifying them as a potential source of transmission of this disease. News Vall d'Hebron hosts the meeting of RECLIP, the network of paediatric clinical trials in Spain During the meeting, the role of the Vall d'Hebron Paediatric Research Hub in promoting research on children and adolescents was highlighted. Pagination First page « Previous page ‹ … Page 5 Page 6 Current page 7 Page 8 Page 9 … Next page › Last page »
